文献速递外周动脉疾病

药物涂层球囊血管成形术中紫杉醇栓塞的实验研究

An Experimental Study of Paclitaxel Embolisation During Drug Coated Balloon Angioplasty.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-03-11

结果显示,在最远端的胫骨前肌中,Ranger组的PTX浓度显著低于Lutonix、In.Pact和Passeo-18 Lux组,Passeo-18 Lux组也显著低于In.Pact组;组织学分析在所有肌肉样本的小动脉中均发现栓塞的PTX晶体,但组间无显著差异。结论提示五种DCB的远端栓塞特征存在差异,临床意义尚待证实。

要点

  • 在胫骨前肌中,Ranger组PTX浓度显著低于Lutonix、In.Pact和Passeo-18 Lux组。
  • Passeo-18 Lux组PTX浓度显著低于In.Pact组。
  • 所有肌肉样本的小动脉中均发现PTX晶体栓塞,但组间无显著差异。

核心结论

  • 五种药物涂层球囊在远端紫杉醇栓塞特征上存在差异。
  • 临床意义尚待证实,但结果可能影响DCB选择,尤其是在严重肢体缺血情况下。

研究设计与样本

  • 结扎右髂总动脉后,在肾下腹主动脉扩张4×40 mm DCB 180秒,2小时后处死动物,采集肾下腹主动脉、血样和三个左后肢肌肉(阔筋膜张肌、股外侧肌、胫骨前肌)进行盲法PTX浓度测量和组织学分析。

主要发现

  • 在胫骨前肌中,Ranger组的PTX浓度(0.067 ng/mg)显著低于Lutonix组(0.342 ng/mg;p = .008)、In.Pact组(0.370 ng/mg;p = .012)和Passeo-18 Lux组(0.160 ng/mg;p = .021)。
  • Passeo-18 Lux组的PTX浓度显著低于In.Pact组(p = .028)。
  • 在阔筋膜张肌和股外侧肌中,各DCB组间的PTX浓度无显著差异。
  • 使用Lutonix后,血浆中PTX浓度显著高于其他四种DCB,而主动脉和使用后DCB上的PTX浓度显著低于其他四种DCB。
  • 组织学分析显示所有肌肉组织样本的小动脉中均有栓塞的PTX晶体证据,但各DCB组间无显著差异。

临床怎么用

  • 选择DCB时需考虑不同产品的远端栓塞特征,尤其在严重肢体缺血情况下。

局限性

  • 临床意义尚未证实。
  • 动物实验模型,结果外推至人类需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Drug coated balloons (DCB) improve the patency of femoropopliteal angioplasty but their use in infrapopliteal lesions is debateable as paclitaxel (PTX) particle embolisation has been suspected in some trials. The aim of this study was to compare experimentally five DCBs in terms of distal embolism of PTX. METHODS: Twenty-five New Zealand rabbits were divided into five groups according to the DCB used: Lutonix (Bard), In.Pact (Medtronic), Passeo-18 Lux (Biotronik), Ranger (Boston Scientific), and Stellarex (Spectranetics) (n = 5 in each group). After ligation of the right common iliac artery, a 4 × 40 mm DCB was inflated in the infrarenal aorta for 180 seconds. Rabbits were euthanised two hours after inflation of the DCB. The infrarenal aorta, a blood sample and three left hind leg muscles (tensor fasciae latae [TFL], vastus lateralis [VL], and tibialis anterior [TA] muscles) were harvested for blind measurement of PTX concentrations and histological analysis (PTX emboli count). RESULTS: In the TA muscle (the most distal), concentrations of PTX were significantly lower for the Ranger (0.067 ng/mg) than for the Lutonix (0.342 ng/mg; p = .008), In.Pact (0.370 ng/mg; p = .012), and Passeo-18-Lux (0.160 ng/mg; p = .021) DCBs. Similarly, concentrations of PTX were significantly lower for the Passeo-18-Lux than for the In.Pact (p = .028). Concentrations of PTX were not significantly different between DCBs in the TFL and VL muscles. Concentrations of PTX were found to be significantly higher in the plasma and lower in the aorta and on the DCBs after use of Lutonix compared with the four other DCBs. Histological analysis revealed evidence of embolised PTX crystals in small arterioles of all muscle tissue samples without any significant difference between the DCBs. CONCLUSIONS: This study suggests some differences regarding distal embolisation profiles between the five assessed DCBs. Although clinical implications remain to be demonstrated, the present results may have implications when choosing a DCB, especially in a critical limb ischaemia setting.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Boitet A, Grassin-Delyle S, Louedec L, et al. An Experimental Study of Paclitaxel Embolisation During Drug Coated Balloon Angioplasty. Eur J Vasc Endovasc Surg. 2019. PMID: 30871939. doi:10.1016/j.ejvs.2018.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。